N. Chin

L. Saiman, N. Chin, P. Della‐Latta, 1999, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

In vitro activity of LY264826 compared to other glycopeptides and daptomycin.

H. Neu, N. Chin, 1991, Diagnostic microbiology and infectious disease.

In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim

H. Neu, N. Chin, 1983, Antimicrobial Agents and Chemotherapy.

Combination of ofloxacin and other antimicrobial agents.

H. Neu, N. Chin, 1990, Journal of chemotherapy.

Synergy of imipenem--a novel carbapenem, and rifampin and ciprofloxacin against Pseudomonas aeruginosa, Serratia marcescens and Enterobacter species.

H. Neu, N. Chin, 1987, Chemotherapy.

A survey of dermatophytes isolated from human patients in the United States from 1993 to 1995.

N. Chin, P. Della‐Latta, I. Weitzman, 1998, Journal of the American Academy of Dermatology.

In vitro activity of fluvastatin, a cholesterol-lowering agent, and synergy with flucanazole and itraconazole against Candida species and Cryptococcus neoformans

N. Chin, P. Della‐Latta, N X Chin, 1997, Antimicrobial agents and chemotherapy.

In vitro activity of Ro 23-6240, a new fluorinated 4-quinolone

H. Neu, N. Chin, D. Brittain, 1986, Antimicrobial Agents and Chemotherapy.

Antibiotic Ciprofloxacin Amoxicillin Ciprofloxacin Norfloxacin Cephalexin Amoxicillin Ciprofloxacin Ciprofloxacin Amoxicillin Ciprofloxacin Norfloxacin Ceftazidime Cephalexin Amoxicillin Trimethoprim Ciprofloxacin Norfloxacin Cephalexin Amoxicillin Trimethoprim Ciprofloxacin Norfloxacin Cefotaxime

H. Neu, N. Chin, 2003 .

Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.

H. Neu, N. Chin, 1987, The American journal of medicine.

In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746

H. Neu, N. Chin, 1988, Antimicrobial Agents and Chemotherapy.

The activity of BMY 28142 a new broad spectrum β-lactamase stable cephalosporin

H. Neu, N. Chin, P. Labthavikul, 1986 .

In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338

H. Neu, N. Chin, A. Novelli, 1989, Antimicrobial Agents and Chemotherapy.

In vitro activity and beta-lactamase stability of two oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074)

H. Neu, N. Chin, P. Labthavikul, 1986, Antimicrobial Agents and Chemotherapy.

Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection

H. Neu, N. Chin, K. Jules, 1986, European Journal of Clinical Microbiology.

In vitro activity and beta-lactamase stability of FK-037, a parenteral cephalosporin

H. Neu, N. Chin, H. Huang, 1993, Antimicrobial Agents and Chemotherapy.

In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones

H. Neu, N. Chin, A. Novelli, 1988, Antimicrobial Agents and Chemotherapy.

In vitro activity of pefloxacin compared to that of quinolones and other antimicrobial agents.

H. Neu, N. Chin, P. Labthavikul, 1984, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.

In vitro activity of SCE-2787, a new cephalosporin with potent activity against Pseudomonas aeruginosa and members of the family Enterobacteriaceae

H. Neu, N. Chin, O. Klein, 1994, Antimicrobial Agents and Chemotherapy.

Pharmacology of ticarcillin combined with clavulanic acid in humans.

H. Neu, N. Chin, B. Scully, 1985, The American journal of medicine.

In vitro activity of fleroxacin in combination with other antimicrobial agents.

H. Neu, N. Chin, 1993, The American journal of medicine.

Intracameral antibiotic agents for endophthalmitis prophylaxis: A pharmacokinetic model

N. Chin, P. Della‐Latta, P. E. Libre, 2003, Journal of cataract and refractive surgery.

In vitro activity of S-ofloxacin

H. Neu, N. Chin, 1989, Antimicrobial Agents and Chemotherapy.

In-vitro activity and β-lactamase stability of LY163892

H. Neu, N. Chin, C. Cao, 1988 .

Comparative antibacterial activity of a new oral cephalosporin, BMY-28100

H. Neu, N. Chin, 1987, Antimicrobial Agents and Chemotherapy.

Activity of cephalosporins against coagulase-negative staphylococci.

H. Neu, N. Chin, N. Neu, 1990, Diagnostic microbiology and infectious disease.

Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969)

H. Neu, N. Chin, A. Novelli, 1988, Antimicrobial Agents and Chemotherapy.

In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosa

H. Neu, N. Chin, A. Novelli, 1988, Antimicrobial Agents and Chemotherapy.

Direct detection and amplification of Helicobacter pylori ribosomal 16S gene segments from gastric endoscopic biopsies.

I. Weinstein, H. Neu, W. Jiang, 1990, Diagnostic microbiology and infectious disease.

Synergy of azlocillin with aminoglycosides.

H. Neu, N. Chin, 1983, The Journal of antimicrobial chemotherapy.

Tazobactam prevention of emergence of resistance.

H. Neu, N. Chin, W. Niu, 1989, Diagnostic microbiology and infectious disease.

The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci, enterobacteriaceae and pseudomonas aeruginosa

H. Neu, N. Chin, P. Labthavikul, 1985, Infection.

The activity of BMY 28142 a new broad spectrum beta-lactamase stable cephalosporin.

H. Neu, N. Chin, P. Labthavikul, 1986, The Journal of antimicrobial chemotherapy.

Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism.

H. Neu, N. Chin, 1984, Diagnostic microbiology and infectious disease.

In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem

H. Neu, N. Chin, P. Labthavikul, 1986, Antimicrobial Agents and Chemotherapy.

In vitro activity of a new cephalosporin ME-1206 compared with other agents.

H. Neu, N. Chin, Y. Zhang, 1991, Diagnostic microbiology and infectious disease.

Nonsusceptible Streptococcus pneumoniae in children with chronic otitis media with effusion and recurrent otitis media undergoing ventilating tube placement

L. Saiman, N. Chin, P. Della‐Latta, 2000, The Pediatric infectious disease journal.

The activity of metal compounds against aerobic and anaerobic bacteria.

H. Neu, N. Chin, 1992, Diagnostic microbiology and infectious disease.

In vitro activity of cefquinome, a new cephalosporin, compared with other cephalosporin antibiotics.

H. Neu, J. Gu, N. Chin, 1992, Diagnostic microbiology and infectious disease.

Resistance of Xanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitors.

H. Neu, N. Chin, G. Saha, 1989, Diagnostic microbiology and infectious disease.

Comparative in vitro activity and beta-lactamase stability of RU29246, the active metabolite of HR916B

H. Neu, N. Chin, K. Yu, 1992, European Journal of Clinical Microbiology and Infectious Diseases.

Comparative in vitro activity of a new quinolone, AM-1091

H. Neu, N. Chin, A. Novelli, 1989, Antimicrobial Agents and Chemotherapy.

In vitro activity and beta-lactamase stability of GR69153, a new long-acting cephalosporin

H. Neu, J. Gu, N. Chin, 1991, Antimicrobial Agents and Chemotherapy.

In vitro activities of two oxazolidinone antimicrobial agents, DuP 721 and DuP 105

H. Neu, N. Chin, A. Novelli, 1988, Antimicrobial Agents and Chemotherapy.

The post-antimicrobial suppressive effect of quinolone agents.

H. Neu, N. Chin, W. Mandell, 1987, Drugs under experimental and clinical research.

In-vitro activity of two new quinolone antimicrobial agents, S-25930 and S-25932 compared with that of other agents.

H. Neu, N. Chin, 1987, The Journal of antimicrobial chemotherapy.

Activity ofA-56268 ComparedwithThatofErythromycin andOther OralAgents against Aerobic andAnaerobic Bacteria

N. Chin, Pornpen Labthavikul, N. Neu, 1987 .

InVitro Activity oftheNewFluoroquinolone CP-99,219

N. Chin, 1994 .

Effect of ciprofloxacin on fecal flora of patients with cystic fibrosis and other patients treated with oral ciprofloxacin.

H. Neu, N. Chin, B. Scully, 1987, The American journal of medicine.